Grant: Operating Grant
McGill University
$319,264.00
Aminopeptidases of malaria parasites: understanding their biochemistry, structure and function for new drug development
EF 2010-11
Résumé
Malaria remains one of the most serious infections of humans worldwide. Over 3 billion people are at risk of infection with
this parasite and 2-3 million die each year, mainly children under the age of five. Due to the global spread of drug resistant
malaria our armoury of drugs available to combat this disease is seriously reduced. Moreover, there is no vaccines available
or in sight. Accordingly, there is an urgent need for us to identify and characterise new parasite targets at which we can
develop new drugs. We have identified enzymes called 'aminopeptidases' in malaria parasites have great potential for new drugs. Here we will study the biochemistry, structure and function of these enzymes to learn more about the mechanism of protein anabolism/catabolism, growth and development in malaria which will forge a new path towards the design of a new class of anti-malarial treatment.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
224240
Name
Dalton John P
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Aminopeptidases of malaria parasites: understanding their biochemistry, structure and function for new drug development
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$319,264
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Aminopeptidases; Biochemistry; Cellular Biology; Enzymology; Malaria; Protein Characterisation
Abstract
Malaria remains one of the most serious infections of humans worldwide. Over 3 billion people are at risk of infection with
this parasite and 2-3 million die each year, mainly children under the age of five. Due to the global spread of drug resistant
malaria our armoury of drugs available to combat this disease is seriously reduced. Moreover, there is no vaccines available
or in sight. Accordingly, there is an urgent need for us to identify and characterise new parasite targets at which we can
develop new drugs. We have identified enzymes called 'aminopeptidases' in malaria parasites have great potential for new drugs. Here we will study the biochemistry, structure and function of these enzymes to learn more about the mechanism of protein anabolism/catabolism, growth and development in malaria which will forge a new path towards the design of a new class of anti-malarial treatment.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dalton, John P
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $319,264~ $0~